The role of AKR1 family in tamoxifen resistant invasive lobular breast cancer based on data mining

BACKGROUND: Tamoxifen (TAM) resistance to invasive lobular cell carcinoma is a challenge for breast cancer treatment. This study explored the role of Aldo-keto reductase family 1 (AKR1) family in tamoxifen-resistant aggressive lobular breast cancer based on data mining. METHODS: TAM-resistant invasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dong, Zhang, Yiqi, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662825/
https://www.ncbi.nlm.nih.gov/pubmed/34886806
http://dx.doi.org/10.1186/s12885-021-09040-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662825/
https://www.ncbi.nlm.nih.gov/pubmed/34886806
http://dx.doi.org/10.1186/s12885-021-09040-8

Ejemplares similares